A Multicenter Study of the Antiviral Efficacy of Entecavir Monotherapy Compared to Lamivudine Monotherapy in Children with Nucleos(t)ide-naïve Chronic Hepatitis B | Zendy

Kyung Jae Lee | Zendy; ByungHo Choe | Zendy; Jae Young Choe | Zendy; Ju Young Kim | Zendy; In Sook Jeong | Zendy; Ju Whi Kim | Zendy; Hye Ran Yang | Zendy; Ju Yuong Chang | Zendy; Kyung Mo Kim | Zendy; Jin Soo Moon | Zendy; Jae Sung Ko | Zendy

Open Access

A Multicenter Study of the Antiviral Efficacy of Entecavir Monotherapy Compared to Lamivudine Monotherapy in Children with Nucleos(t)ide-naïve Chronic Hepatitis B

Author(s) -

Kyung Jae Lee,

ByungHo Choe,

Jae Young Choe,

Ju Young Kim,

In Sook Jeong,

Ju Whi Kim,

Hye Ran Yang,

Ju Yuong Chang,

Kyung Mo Kim,

Jin Soo Moon,

Jae Sung Ko

Publication year - 2018

Publication title -

journal of korean medical science

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.743

H-Index - 66

eISSN - 1598-6357

pISSN - 1011-8934

DOI - 10.3346/jkms.2018.33.e63

Subject(s) - entecavir , medicine , lamivudine , seroconversion , gastroenterology , hbeag , concomitant , hepatitis b , hepatitis b virus , chronic hepatitis , nucleoside analogue , adefovir , immunology , hbsag , nucleoside , virus , biology , biochemistry

ETV is superior to LAM in pediatric CHB treatment because of its higher virologic suppression rate and lower cumulative rates of virologic breakthrough and genotypic mutation.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research